Publications
2025
2024
2023
-
Martel F, Cuervo-Rojas J, Angel J, Ariza B, Gonzalez JM…………. Franco Manuel. Cross-reactive humoral and CD4+ T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian population. Front. Immunol., 27 July 2023. Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1241038
-
Puerta CJ, Cuellar A, Lasso P, Mateus J and Gonzalez JM (2023) Trypanosoma cruzi-specific CD8+ T cells and other immunological hallmarks in chronic Chagas cardiomyopathy: Two decades of research. Front. Cell. Infect. Microbiol. 12:1075717. doi: 10.3389/fcimb.2022.1075717.
2022
-
Ramirez Varela A….., González JM, Santos-Barbosa JC……, CoVIDA Working GroupEffectiveness and adherence to closed face shields in the prevention of COVID-19 transmission: a non-inferiority randomized controlled trial in a middle-income setting (COVPROSHIELD) Trials. 2022 Aug 20;23(1):698. doi: 10.1186/s13063-022-06606-0.
-
Lu S, Duplat D, Benitez-Bolivar, León C, Villota SD……Gonzalez JM……..Bremner R. Multicenter international assessment of a SARS-CoV-2 RT-LAMP test for point of care clinical application. PLOS 2022. https://doi.org/10.1371/journal.pone.0268340
2021
2020
-
MS Gonzalez, & JM GonzalezDouble positive T lymphocytes do not vary in different age groups in Colombian Blood Donor. urk J Hematol 2020;37:125-138
-
John M Gonzalez, Jeremy W Shelton, Manuel Diaz-Vallejo, Victoria E Rodriguez-Castellanos, Juan Diego H Zuluaga, Diego F Chamorro, Daniel Arroyo-Ariza. Immunological assays for SARS-CoV-2: an analysis of available commercial tests to measure antigen and antibodies. MedRxiv April 14 2020. doi: https://doi.org/10.1101/2020.04.10.20061150
2019
-
González-Mancera MS, Bolaños NI, Salamanca M, Orjuela GA, Rodriguez AN, Gonzalez JM Percentages of CD4+CD8+ double-positive T lymphocytes in the peripheral blood of adults from a blood bank in Bogotá, Colombia. Turkish Journal of Hematology, aceptado.
-
Mateus J, Guerrero P, Lasso P, Cuervo C, González JM, Puerta JM and Cuellar A. An animal model of acute and chronic Chagas disease with the reticulotropic Y strain of Trypanosoma cruzi that depicts the multifunctionality and dysfunctionality of T cells.Front. Immunol. | doi: 10.3389/fimmu.2019.00918
-
Lasso P, Mateus J, González JM, Cuéllar A, Puerta C. CD8+ T Cell Response to Trypanosoma cruzi Antigens during Chronic Chagas Disease. Methods Mol Biol. 2019;1955:349-361. doi: 10.1007/978-1-4939-9148-8_26.
2018
-
Pérez-Antón E, Egui A, Thomas MC, Puerta CJ, González JM, Cuéllar A, Segovia M, López MC. Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients. PLoS Negl Trop Dis. 2018 May 11;12(5):e0006480. doi: 10.1371/journal.pntd.0006480.
-
Panesso-Gómez S, Pavia P, Rodríguez-Mantilla IE, Lasso P, Orozco LA, Cuellar A, Puerta CJ, Mendoza de Molano B, González JM. Trypanosoma cruzi Detection in Colombian Patients with a Diagnosis of Esophageal Achalasia. Am J Trop Med Hyg. 2018 Feb 5. doi: 10.4269/ajtmh.17-0417
2017
-
Duran-Rehbein GA, Vargas-Zambrano JC, Cuéllar A, Puerta, C, Gonzalez JM. Induction of cellular proliferation in a human astrocytoma cell line by a Trypanosoma cruzi-derived antigen: a mechanism of pathogenesis? Cellular and Molecular Biology 63 (1) 23-67
2016
-
Lasso P, Cárdenas C, Guzmán F, Rosas F, Thomas MC, López MC, González JM, Cuéllar A, Campanera JM, Luque FJ, Puerta CJ.
Effect of secondary anchor amino acid substitutions on the immunogenic properties of an HLA-A*0201-restricted T cell epitope derived from the Trypanosoma cruzi KMP-11 protein.Peptides. 2016 Feb 5. pii: S0196-9781(16)30018-3. doi: 10.1016/j.peptides.2016.02.002.
2015
-
Lasso P, Mateus J, Pavía P, Rosas F, Roa N, Thomas MC, López MC, Gonzále JM, Puerta JC and Cuellar A. Inhibitory Receptor Expression on CD8+ T Cells Is Linked to Functional Responses against Trypanosoma cruzi Antigens in Chronic Chagasic Patients. Journal of Immunology J Immunol. 2015 Oct 15;195(8):3748-58. doi: 10.4049/jimmunol.1500459
2014
-
Llano M, Pavia P, Florez AC, Cuéllar A, González JM, Puerta CJ.Evaluación preliminar de la prueba comercial “Chagas (Trypanosoma cruzi) IgG-ELISA®” en individuos colombianos . Biomedica 2014 34 (2)
2013
2012
-
Rico A, Mateus J, Lasso P, Gonzalez JM, Puerta CJ, Cuellar A. Expresión de receptores inhibidores en linfocitos T CD4+ y CD8+ de donantes sanos Colombianos. Universitas Scientiarium 2012, 17 (1):35-42
2011
2010
2009
2007
2006